The Orphan Drug Comparator: a survey to identify challenges in price negotiations with AIFA
In collaboration with Rarelab, we launched a survey with the aim of assessing the actual impact of the use of comparators in the negotiation of orphan drugs, drugs that for
6 February 2024
